• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球特应性皮炎的疾病负担、发病率和伤残调整生命年:1990-2019 年与社会经济发展状况相结合的系统分析。

Global Burden, Incidence and Disability-Adjusted Life-Years for Dermatitis: A Systematic Analysis Combined With Socioeconomic Development Status, 1990-2019.

机构信息

Department of Burns and Plastic and Wound Repair Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

School of Medicine, Xiamen University, Xiamen, China.

出版信息

Front Cell Infect Microbiol. 2022 Apr 12;12:861053. doi: 10.3389/fcimb.2022.861053. eCollection 2022.

DOI:10.3389/fcimb.2022.861053
PMID:35493737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9039287/
Abstract

BACKGROUND

Dermatitis is an important global health problem that not only affects social interaction and physical and mental health but also causes economic burden. Health problems or distress caused by dermatitis may be easily overlooked, and relevant epidemiological data are limited. Therefore, a better understanding of the burden of dermatitis is necessary for developing global intervention strategies.

METHODS

All data on dermatitis, including atopic dermatitis (AD), contact dermatitis (CD) and seborrhoeic dermatitis (SD), were obtained from the Global Burden of Disease 2019 (GBD2019) database. The extracted age-standardized incidence rates (ASIR) and disability-adjusted life-years (DALYs) rates (ASDR) data were analysed by stratification, including by sex, country or region, and sociodemographic index (SDI) indicators. Finally, we analysed the correlation between the global burden of dermatitis and socioeconomic development status.

RESULTS

According to the GBD 2019 estimate, the ASIR and ASDR for the three major types of dermatitis in 2019 were 5244.3988 (95% CI 4551.7244-5979.3176) per 100,000 person-years and 131.6711 (95% CI 77.5876-206.8796) per 100,000 person-years. The ASIR and ASDR of atopic dermatitis, contact dermatitis and seborrhoeic dermatitis are: Incidence (95%CI,per 100,000 person-years), 327.91 (312.76-343.67), 3066.04 (2405.38-3755.38), 1850.44 (1706.25- 1993.74); DALYs (95%CI, per 100,000 person-years), 99.69 (53.09-167.43), 28.06 (17.62-41.78), 3.93 (2.24-6.25). In addition, among the three dermatitis types, the greatest burden was associated with AD. According to the ASDR from 1990 to 2019, the burden of dermatitis has exhibited a slow downward trend in recent years. In 2019, the ASIR showed that the USA had the greatest burden, while the ASDR showed that Asian countries (such as Japan, Mongolia, Kazakhstan, and Uzbekistan) and some European countries (France, Estonia) had the greatest burden. According to SDI stratification and the three major dermatitis types, high ASIR and ASDR corresponded to high SDI areas (especially for AD).

CONCLUSION

The burden of dermatitis is related to socioeconomic development status, especially for AD, which is positively correlated with the SDI. The results based on GBD2019 data are valuable for formulating policy, preventing and treating dermatitis and reducing the global burden of dermatitis.

摘要

背景

皮炎是一个重要的全球性健康问题,不仅影响社交互动和身心健康,还会造成经济负担。皮炎引起的健康问题或痛苦可能很容易被忽视,相关的流行病学数据也有限。因此,了解皮炎的负担对于制定全球干预策略非常必要。

方法

所有关于皮炎的数据,包括特应性皮炎(AD)、接触性皮炎(CD)和脂溢性皮炎(SD),均从 2019 年全球疾病负担(GBD2019)数据库中获得。通过分层分析提取的年龄标准化发病率(ASIR)和伤残调整生命年(DALY)率(ASDR)数据,包括性别、国家或地区和社会人口学指数(SDI)指标。最后,我们分析了皮炎的全球负担与社会经济发展状况之间的相关性。

结果

根据 GBD2019 的估计,2019 年三种主要皮炎类型的 ASIR 和 ASDR 分别为每 100000 人年 5244.3988(95%CI 4551.7244-5979.3176)和每 100000 人年 131.6711(95%CI 77.5876-206.8796)。特应性皮炎、接触性皮炎和脂溢性皮炎的 ASIR 和 ASDR 分别为:发病率(95%CI,每 100000 人年),327.91(312.76-343.67)、3066.04(2405.38-3755.38)、1850.44(1706.25-1993.74);伤残调整生命年(95%CI,每 100000 人年),99.69(53.09-167.43)、28.06(17.62-41.78)、3.93(2.24-6.25)。此外,在三种皮炎类型中,AD 造成的负担最大。根据 1990 年至 2019 年的 ASDR,近年来皮炎的负担呈缓慢下降趋势。2019 年,ASIR 显示美国的负担最大,而 ASDR 显示亚洲国家(如日本、蒙古、哈萨克斯坦和乌兹别克斯坦)和一些欧洲国家(法国、爱沙尼亚)的负担最大。根据 SDI 分层和三种主要的皮炎类型,高 ASIR 和 ASDR 对应高 SDI 地区(尤其是 AD)。

结论

皮炎的负担与社会经济发展状况有关,特别是 AD,与 SDI 呈正相关。基于 GBD2019 数据的结果对于制定政策、预防和治疗皮炎以及减轻全球皮炎负担非常有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/578b13c56f6f/fcimb-12-861053-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/dddea8cabaa2/fcimb-12-861053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/7756bf238a71/fcimb-12-861053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/d693db74c546/fcimb-12-861053-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/578b13c56f6f/fcimb-12-861053-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/dddea8cabaa2/fcimb-12-861053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/7756bf238a71/fcimb-12-861053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/d693db74c546/fcimb-12-861053-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c7/9039287/578b13c56f6f/fcimb-12-861053-g004.jpg

相似文献

1
Global Burden, Incidence and Disability-Adjusted Life-Years for Dermatitis: A Systematic Analysis Combined With Socioeconomic Development Status, 1990-2019.全球特应性皮炎的疾病负担、发病率和伤残调整生命年:1990-2019 年与社会经济发展状况相结合的系统分析。
Front Cell Infect Microbiol. 2022 Apr 12;12:861053. doi: 10.3389/fcimb.2022.861053. eCollection 2022.
2
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
3
Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的气管、支气管和肺癌的时间趋势,与全球数据比较。
Thorac Cancer. 2023 Jun;14(18):1668-1706. doi: 10.1111/1759-7714.14912. Epub 2023 May 1.
4
Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.全球、区域和国家层面精神分裂症发病率和伤残调整寿命年趋势:来自 2017 年全球疾病负担研究的结果。
Epidemiol Psychiatr Sci. 2020 Jan 13;29:e91. doi: 10.1017/S2045796019000891.
5
Current status and temporal trend in incidence, death, and burden of esophageal cancer from 1990-2019.1990-2019 年食管癌发病、死亡和疾病负担的现状及时间趋势。
Thorac Cancer. 2023 Aug;14(24):2408-2458. doi: 10.1111/1759-7714.15028. Epub 2023 Jul 13.
6
Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017.全球、区域和国家层面双相情感障碍的发病率及伤残调整生命年趋势:2017年全球疾病负担研究结果
J Psychiatr Res. 2020 Jun;125:96-105. doi: 10.1016/j.jpsychires.2020.03.015. Epub 2020 Mar 27.
7
Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019.全球急性病毒性肝炎负担及其与社会经济发展状况的关系,1990-2019 年。
J Hepatol. 2021 Sep;75(3):547-556. doi: 10.1016/j.jhep.2021.04.035. Epub 2021 May 4.
8
The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.204 个国家和地区非酒精性脂肪性肝病的全球、区域和国家负担及趋势:基于 2019 年全球疾病负担研究的分析。
JMIR Public Health Surveill. 2022 Dec 12;8(12):e34809. doi: 10.2196/34809.
9
Global, regional, and national burdens of myocarditis, 1990-2019: systematic analysis from GBD 2019 : GBD for myocarditis.全球、区域和国家心肌炎负担,1990-2019 年:来自 GBD 2019 的系统分析:心肌炎的 GBD。
BMC Public Health. 2023 Apr 19;23(1):714. doi: 10.1186/s12889-023-15539-5.
10
Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年男性归因于吸烟的前列腺癌全球负担。
BMC Cancer. 2023 Jan 26;23(1):92. doi: 10.1186/s12885-023-10552-8.

引用本文的文献

1
Global and Regional Burden of Seborrheic Dermatitis: Trends in Incidence and DALYs, 1990-2021.脂溢性皮炎的全球和区域负担:1990年至2021年发病率和伤残调整生命年的趋势
Clin Cosmet Investig Dermatol. 2025 Jun 4;18:1389-1400. doi: 10.2147/CCID.S527551. eCollection 2025.
2
The Supporting Role of Hyperbaric Oxygen Therapy in Atopic Dermatitis Treatment.高压氧疗法在特应性皮炎治疗中的辅助作用
J Clin Med. 2025 May 1;14(9):3138. doi: 10.3390/jcm14093138.
3
Global burden of viral skin diseases from 1990 to 2021: a systematic analysis for the global burden of disease study 2021.

本文引用的文献

1
Contact dermatitis.接触性皮炎。
Nat Rev Dis Primers. 2021 May 27;7(1):38. doi: 10.1038/s41572-021-00271-4.
2
Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.健康生命年治疗速度成本:来自 7 项随机临床试验的个体患者数据的荟萃分析。 **解析**: - Healthy Life-Year(健康生命年):这是一个医学术语,用于衡量一个人在健康状态下的生存时间。 - Treatment Speed(治疗速度):指的是从到达医院到开始接受血管内血栓切除术的时间。 - Ischemic Stroke(缺血性中风):一种由于脑血管阻塞导致的脑部缺血性疾病。 - Meta-analysis(荟萃分析):一种统计学方法,用于综合和分析多个研究的结果。 - Individual Patient Data(个体患者数据):指的是每个患者的详细医疗记录和数据。 - Randomized Clinical Trial(随机临床试验):一种医学研究方法,用于评估新的治疗方法的效果。
JAMA Neurol. 2021 Jun 1;78(6):709-717. doi: 10.1001/jamaneurol.2021.1055.
3
1990年至2021年病毒性皮肤病的全球负担:全球疾病负担研究2021的系统分析
Front Public Health. 2025 Feb 19;13:1464372. doi: 10.3389/fpubh.2025.1464372. eCollection 2025.
4
Economic burden of atopic dermatitis in Portugal: a cross-sectional study.葡萄牙特应性皮炎的经济负担:一项横断面研究。
Sci Rep. 2025 Mar 5;15(1):7717. doi: 10.1038/s41598-025-91896-y.
5
Role of immune cells in seborrheic dermatitis: a two-sample bidirectional Mendelian randomization study.免疫细胞在脂溢性皮炎中的作用:一项两样本双向孟德尔随机化研究
Arch Dermatol Res. 2025 Feb 24;317(1):482. doi: 10.1007/s00403-025-04028-x.
6
Global, regional, and national burden of seborrheic dermatitis in individuals aged 55 and older from 1990 to 2021: a trend analysis and future projections.1990年至2021年55岁及以上人群脂溢性皮炎的全球、区域和国家负担:趋势分析与未来预测
Arch Dermatol Res. 2025 Feb 8;317(1):381. doi: 10.1007/s00403-025-03870-3.
7
The economic burden of atopic dermatitis in Romania: a broad perspective.罗马尼亚特应性皮炎的经济负担:全面视角
Front Public Health. 2025 Jan 9;12:1531042. doi: 10.3389/fpubh.2024.1531042. eCollection 2024.
8
Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series.1%他扎罗汀乳膏每日一次在脂溢性皮炎患者中的真实世界应用:病例系列
J Clin Aesthet Dermatol. 2025 Jan;18(1):24-28.
9
Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways.牛蒡子苷通过抑制TLR4/MyD88/NF-κB和NLRP3/Caspase-1/GSDMD信号通路减轻特应性皮炎的炎症和焦亡。
J Inflamm Res. 2024 Nov 2;17:8009-8026. doi: 10.2147/JIR.S484919. eCollection 2024.
10
Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey.美国患者和医疗服务提供者对脂溢性皮炎疾病负担的看法:一项全国性调查结果
Dermatol Ther (Heidelb). 2024 Nov;14(11):3083-3095. doi: 10.1007/s13555-024-01288-9. Epub 2024 Oct 28.
Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis.特应性皮炎管理中的全身治疗:一项系统评价与荟萃分析。
Allergy. 2021 Apr;76(4):1053-1076. doi: 10.1111/all.14631. Epub 2020 Nov 4.
4
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
5
Five insights from the Global Burden of Disease Study 2019.2019 年全球疾病负担研究的五个洞见。
Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5.
6
Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China.中国一项横断面研究:脂溢性皮炎患者的临床特征和生活质量。
Health Qual Life Outcomes. 2020 Sep 16;18(1):308. doi: 10.1186/s12955-020-01558-y.
7
Atopic dermatitis.特应性皮炎。
Lancet. 2020 Aug 1;396(10247):345-360. doi: 10.1016/S0140-6736(20)31286-1.
8
Hand hygiene during COVID-19: Recommendations from the American Contact Dermatitis Society.COVID-19 期间的手部卫生:美国接触性皮炎学会的建议。
J Am Acad Dermatol. 2020 Dec;83(6):1730-1737. doi: 10.1016/j.jaad.2020.07.057. Epub 2020 Jul 22.
9
American Contact Dermatitis Society Allergens of the Year 2000 to 2020.美国接触性皮炎学会 2000 年至 2020 年过敏原。
Dermatol Clin. 2020 Jul;38(3):309-320. doi: 10.1016/j.det.2020.02.011. Epub 2020 Apr 25.
10
Facial Dermatitis in Male Patients Referred for Patch Testing: Retrospective Analysis of North American Contact Dermatitis Group Data, 1994 to 2016.男性患者因斑贴试验就诊的面部皮炎:1994 年至 2016 年北美接触性皮炎组数据的回顾性分析。
JAMA Dermatol. 2020 Jan 1;156(1):79-84. doi: 10.1001/jamadermatol.2019.3531.